Introduction.
The study of modifiable cardiometabolic risk factors (CMRFs) influencing the clinical phenotype of hypertrophic cardiomyopathy (HCM) is currently relevant. It is known that modifier genes can affect the course and progression of symptoms in HCM. At the same time, the analysis of associations between si...
T. Bezhanishvili, E. Semernin, V. G. Ilyina et al.· The Scientific Notes of the...· 0 citations
For most diseases, whether PRS improves prediction beyond clinical data remains unknown, as existing evidence is concentrated in a handful of conditions with established risk models. Using 900,000 participants from UK Biobank and FinnGen, we developed and validated models for predicting 150 diseases and all-cause morta...
D. Usoltsev, I. Molotkov, N. Kolosov et al.· medRxiv· 0 citations
Aim
.
To characterize the pregnancy and postpartum period in carriers of truncating
TTN
gene variants with a phenotype of dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) with increased left ventricular (LV) trabeculation, and to evaluate the potential role of pregnancy as a trigger for deco...
I. S. Danilevich, E. Karelkina, A. Ryzhkov et al.· Russian Journal of Cardiolog...· 0 citations
ROBO1 can be regarded as a candidate gene associated with combined heart and kidney structural defects and should be included in appropriate diagnostic gene-sequencing panels and support the usefulness of WES and array-based comparative genomic hybridization (array-CGH) analysis for new candidate gene identification, m...
A. Zlotina, Sergei Zhuk, I. Kozyrev et al.· Frontiers in Cell and Develo...· 0 citations
Goflikicept effectively normalized dysregulated immune responses in IRP, supporting the broader therapeutic potential of IL-1 blockade in NLRP3-mediated inflammatory diseases.
A. Golovkin, E. Markelova, E. Ignatieva et al.· Inflammation Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.